Floatz logo

RETINOL

Dry Eye Syndromes

Dr Cipto Mangunkusumo General HospitalSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Dry Eye Syndromes cohort.

Asset / SponsorPhaseRating
Sodium Hyaluronate
Peking University Third Hospital
Phase 4BB
VITAMIN D
University of Faisalabad
Phase 3BB
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
Seema Capoor
Phase 1CC
Alpha Tocopherol
Dr Cipto Mangunkusumo General Hospital
N/AD

Same molecule, other indications

RETINOL is also rated in:

relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
65 / 100
View asset →
tuberculosisDormant
BB
Indicative ·
64 / 100
View asset →
vitamin A deficiencyDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →